AstraZeneca PLC ADR (USD)
AZN
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range53.46 | 54.07
52-Wk Range- | -
Last Close-
Mkt Cap (m)-
Dividend yield-
ISINUS0463531089
Volume4,591,334.00
Exchange VenueNYS

Company Profile

AstraZeneca PLC belongs to the healthcare sector. The company develops and markets pharmaceutical products for various therapeutic classes such as gastrointestinal, cardiovascular, respiratory, cancer, immunology, and neuroscience.

Key Information
Price/Earning-
Price/Book-
Price/Sales-
P/CF-
Rev Growth (3 year avg)1.96
EPS Growth (3 year avg)-0.28
Operating Margin % 6.98
Net Margin %5.47
Return on Equity10.43
Debt/Equity1.39

Documents

Prospectus
en 11/06/2020
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

http://www.astrazeneca.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)26,095.0024,708.0023,002.0022,465.0022,090.0024,384.00
Operating Income (m)2,087.004,114.003,572.002,292.001,510.001,702.00
Net Income (m)1,233.002,825.003,499.003,001.002,155.001,335.00
Basic EPS0.491.121.391.190.850.52
Avg. Diluted Shares Outstanding (m)2,528.002,530.002,532.002,534.002,534.002,602.00
Balance Sheet
USD201420152016201720182019
Current Assets (m)16,697.0016,007.0013,262.0013,150.0015,591.0015,563.00
Non Current Assets (m)41,898.0044,117.0049,264.0050,204.0045,060.0045,814.00
Total Assets (m)58,595.0060,124.0062,526.0063,354.0060,651.0061,377.00
Current Liabilities (m)17,330.0014,869.0015,256.0016,383.0016,292.0018,117.00
Total Liabilities (m)------
Total Equity (m)19,627.0018,490.0014,854.0014,960.0012,468.0013,127.00
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)7,058.003,324.004,145.003,578.002,618.002,969.00
Capital Expenditure (m)-2,752.00-2,788.00-2,314.00-1,620.00-1,371.00-2,460.00
Figures are quoted in USD unless stated otherwise
$
53.80
Last Price